253 related articles for article (PubMed ID: 33546485)
1. Anti-SU Antibody Responses in Client-Owned Cats Following Vaccination against Feline Leukaemia Virus with Two Inactivated Whole-Virus Vaccines (Fel-O-Vax
Westman M; Norris J; Malik R; Hofmann-Lehmann R; Parr YA; Armstrong E; McDonald M; Hall E; Sheehy P; Hosie MJ
Viruses; 2021 Feb; 13(2):. PubMed ID: 33546485
[TBL] [Abstract][Full Text] [Related]
2. The Diagnosis of Feline Leukaemia Virus (FeLV) Infection in Owned and Group-Housed Rescue Cats in Australia.
Westman M; Norris J; Malik R; Hofmann-Lehmann R; Harvey A; McLuckie A; Perkins M; Schofield D; Marcus A; McDonald M; Ward M; Hall E; Sheehy P; Hosie M
Viruses; 2019 May; 11(6):. PubMed ID: 31159230
[TBL] [Abstract][Full Text] [Related]
3. Development and testing of an inactivated feline leukemia virus vaccine.
Hoover EA; Mullins JI; Chu HJ; Wasmoen TL
Semin Vet Med Surg Small Anim; 1995 Nov; 10(4):238-43. PubMed ID: 8820598
[TBL] [Abstract][Full Text] [Related]
4. Antibody Responses in Cats Following Primary and Annual Vaccination against Feline Immunodeficiency Virus (FIV) with an Inactivated Whole-Virus Vaccine (Fel-O-Vax
Westman M; Yang D; Green J; Norris J; Malik R; Parr YA; McDonald M; Hosie MJ; VandeWoude S; Miller C
Viruses; 2021 Mar; 13(3):. PubMed ID: 33809232
[TBL] [Abstract][Full Text] [Related]
5. Diagnosing feline immunodeficiency virus (FIV) and feline leukaemia virus (FeLV) infection: an update for clinicians.
Westman ME; Malik R; Norris JM
Aust Vet J; 2019 Mar; 97(3):47-55. PubMed ID: 30809813
[TBL] [Abstract][Full Text] [Related]
6. Measuring the Humoral Immune Response in Cats Exposed to Feline Leukaemia Virus.
Parr YA; Beall MJ; Levy JK; McDonald M; Hamman NT; Willett BJ; Hosie MJ
Viruses; 2021 Mar; 13(3):. PubMed ID: 33800090
[TBL] [Abstract][Full Text] [Related]
7. Protection against feline leukemia virus infection by use of an inactivated virus vaccine.
Hoover EA; Perigo NA; Quackenbush SL; Mathiason-DuBard CK; Overbaugh JM; Kloetzer WS; Elder JH; Mullins JI
J Am Vet Med Assoc; 1991 Nov; 199(10):1392-401. PubMed ID: 1666090
[TBL] [Abstract][Full Text] [Related]
8. Feline leukemia virus immunity induced by whole inactivated virus vaccination.
Torres AN; O'Halloran KP; Larson LJ; Schultz RD; Hoover EA
Vet Immunol Immunopathol; 2010 Mar; 134(1-2):122-31. PubMed ID: 20004483
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of an inactivated FeLV vaccine compared to a recombinant FeLV vaccine in minimum age cats following virulent FeLV challenge.
Stuke K; King V; Southwick K; Stoeva MI; Thomas A; Winkler MT
Vaccine; 2014 May; 32(22):2599-603. PubMed ID: 24662705
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of an inactivated feline leukemia virus vaccine.
Hoover EA; Mullins JI; Chu HJ; Wasmoen TL
AIDS Res Hum Retroviruses; 1996 Mar; 12(5):379-83. PubMed ID: 8882314
[TBL] [Abstract][Full Text] [Related]
11. Protection from challenge following administration of a canarypox virus-vectored recombinant feline leukemia virus vaccine in cats previously vaccinated with a killed virus vaccine.
Grosenbaugh DA; Leard T; Pardo MC
J Am Vet Med Assoc; 2006 Mar; 228(5):726-7. PubMed ID: 16506935
[TBL] [Abstract][Full Text] [Related]
12. Recombinant FeLV vaccine: long-term protection and effect on course and outcome of FIV infection.
Hofmann-Lehmann R; Holznagel E; Aubert A; Ossent P; Reinacher M; Lutz H
Vet Immunol Immunopathol; 1995 May; 46(1-2):127-37. PubMed ID: 7618252
[TBL] [Abstract][Full Text] [Related]
13. Duration of antibody response following vaccination against feline immunodeficiency virus.
Westman ME; Malik R; Hall E; Harris M; Hosie MJ; Norris JM
J Feline Med Surg; 2017 Oct; 19(10):1055-1064. PubMed ID: 27770018
[TBL] [Abstract][Full Text] [Related]
14. Protection against feline leukemia virus challenge for at least 2 years after vaccination with an inactivated feline leukemia virus vaccine.
Jirjis FF; Davis T; Lane J; Carritt K; Sweeney D; Williams J; Wasmoen T
Vet Ther; 2010; 11(2):E1-6. PubMed ID: 20957616
[TBL] [Abstract][Full Text] [Related]
15. Field Performance of a Rapid Test to Detect Progressive, Regressive, and Abortive Feline Leukemia Virus Infections in Domestic Cats in Australia and Germany.
Westman ME; Giselbrecht J; Norris JM; Malik R; Green J; Burton-Bradley E; Cheang A; Meili T; Meli ML; Hartmann K; Hofmann-Lehmann R
Viruses; 2023 Feb; 15(2):. PubMed ID: 36851705
[TBL] [Abstract][Full Text] [Related]
16. Vaccination of cats experimentally infected with feline immunodeficiency virus, using a recombinant feline leukemia virus vaccine.
Lehmann R; Franchini M; Aubert A; Wolfensberger C; Cronier J; Lutz H
J Am Vet Med Assoc; 1991 Nov; 199(10):1446-52. PubMed ID: 1666101
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the efficacy of three commercial feline leukemia virus vaccines in a natural challenge exposure.
Legendre AM; Hawks DM; Sebring R; Rohrbach B; Chavez L; Chu HJ; Acree WM
J Am Vet Med Assoc; 1991 Nov; 199(10):1456-62. PubMed ID: 1666103
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and efficacy of a commercial feline leukemia virus vaccine.
Pedersen NC
J Vet Intern Med; 1993; 7(1):34-9. PubMed ID: 8384261
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the safety and efficacy of a recombinant feline leukemia virus (FeLV) vaccine delivered transdermally and an inactivated FeLV vaccine delivered subcutaneously.
Grosenbaugh DA; Leard T; Pardo MC; Motes-Kreimeyer L; Royston M
Vet Ther; 2004; 5(4):258-62. PubMed ID: 15719325
[TBL] [Abstract][Full Text] [Related]
20. Serological differentiation of FIV-infected cats from dual-subtype feline immunodeficiency virus vaccine (Fel-O-Vax FIV) inoculated cats.
Kusuhara H; Hohdatsu T; Seta T; Nemoto K; Motokawa K; Gemma T; Watanabe R; Huang C; Arai S; Koyama H
Vet Microbiol; 2007 Mar; 120(3-4):217-25. PubMed ID: 17141431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
